Hafsat Rufai Ahmad

Prof. Hafsat Rufai Ahmad

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 May 2023 in medRxiv
Verified
Preprint
Open access
PDF file
OOOyesola O. Ojewunmi
Oyesola O. Ojewunmi
TATitilope A. Adeyemo
Titilope A. Adeyemo
AOAjoke I. Oyetunji
Ajoke I. Oyetunji
BIBassey Inyang
Bassey Inyang
AAAfolashade Akinrindoye
Afolashade Akinrindoye
SMStephan Menzel
Stephan Menzel
Background: The clinical severity of sickle cell disease (SCD) is strongly influenced by the level of fetal haemoglobin (HbF) persistent in each patient. Three major HbF loci ( BCL11A , HBS1L-MYB , and Xmn1-HBG2 ) have been reported, but a considerable hidden heritability remains. Aim: Building on the power of a large and genetically diverse patient pool present in Nigeria, we conducted a genome-wide association study for HbF levels in patients from three regions of the country with a diverse ethnic make-up. Methods: We analysed genome-wide trait association in 1006 Nigerian patients with SCD (HbSS/HbSβ 0 ), followed by a replication and meta-analysis exercise in four independent SCD cohorts (3,582 patients). To dissect association signals at the major loci, we performed stepwise conditional analysis, haplotype association analysis and included public functional annotation data (fGCTA). Results: Association signals were detected for BCL11A (lead SNP rs6706648, β=- 0.39, P =4.96 x 10 -34 ) and HBS1L-MYB (lead SNP rs61028892, β=0.73, P =1.18 x 10 -9 ), whereas the variant allele for Xmn1-HBG2 was found to be very rare. Genetically dissecting the two major loci, we defined trait-boosting haplotypes containing suspected or so-far unidentified causal variants. At BCL11A , one such haplotype (trait increase P < 0.0001) contains the putative functional variant rs1427407-‘T’ and a second haplotype ( P < 0.0001) is tagged by the rs7565301-‘A’ allele, with no obvious candidate causal variant. At HBS1L- MYB , one haplotype (trait increase P < 0.0001) contains the likely functional rs66650371 (Δ3-bp), and a second ( P < 0.0001) is tagged by the ‘C’ allele of rs6102889. Together, variants at BCL11A and HBS1L-MYB SNPs explained 24.1% of the trait variance. We detected three novel association signals: SLC28A3 on chromosome 9 (rs115555854: β=- 0.73, P =2.52 x 10 -8 ), TICRR on chromosome 15 (rs140496989: β=-0.43, P =3.34 x 10 -8 ), and PIEZO2 on chromosome 18 (rs58817161: β= −0.63, P = 8.04 x 10 -8 ). These appeared to be restricted to the Nigerian patient cohort and were not confirmed in the replication cohorts. Conclusions: Studying a diverse cohort of Nigerian patients with sickle cell disease, we genetically dissected the known fetal-haemoglobin loci BCL11A and HBS1L-MYB and detected putative new trait-associated regions.

Verified
Journal Article
Open access
PDF file
ASAmos Solomon
Amos Solomon
SAShofoluwe Nurudeen Adebola
Shofoluwe Nurudeen Adebola
IAIsa Abdulkadir
Isa Abdulkadir
HAHafsat Rufai Ahmad
Hafsat Rufai Ahmad
MBMohammed Ibrahim Babatunde
Mohammed Ibrahim Babatunde
UAUsman Mohammed Aminu
Usman Mohammed Aminu
Sickle Cell Disease (SCD) can result in painful vascular occlusion crises, anoxia, and ischemia, which can occasionally cause damage to tissues and organs, including the auditory system, particularly the blood-rich cochlea. Despite being underreported, Sensorineural Hearing Loss (SNHL) is a well-known consequence of SCD globally. The study’s objective was to determine the prevalence and pattern of hearing loss in children and adolescents aged 5 to 16 years old with SCD who were in steady state and were seen at the hematology and pediatric outpatient clinics at Ahmadu Bello University Teaching Hospital (ABUTH), Zaria, Nigeria. A prospective hospital-based case-control study was conducted with 125 children with SCD in steady state, aged 5 to 16, who were enrolled in the hematology clinic at the Ahmadu Bello University Teaching Hospital in Zaria, Nigeria, and 125 ‘age- and sex-matched healthy controls, who were selected from the ABUTH’s pediatric outpatient clinics. An organized questionnaire was used to collect fundamental data on the sociodemographic characteristics and medical history of the participants and controls. In a sound-treated booth, the participant’s hearing was evaluated using tympanometry and pure tone audiometry. Overall, 68 (54.4%) and 57 (45.6%) out of the 125 assessed participants were male and female, respectively, with a male-to-female ratio of 1.2:1 and the mean age 10.17±3.55 years. Due to age-sex matching, the subject’s age and sex distributions match those of the controls. Children with SCD experienced bilateral SNHL ≥25 dB in 32/125 (25.6%) cases (21 males;11 females). The control group, which had a HbAA phenotype that was normal, did not exhibit any hearing loss. 21/32 (65.6%) of the participants had mild (26-40 dB) hearing loss, and SNHL occurred more frequently in males (21/32 (65.6%) than in females (11/32 (34.4%). In comparison to 3(9.4%) HbSC and 1(3.1%) HbSS+F, SNHL was more common in individuals with 28(87.5%) HbSS phenotypes. While diverse frequencies were impacted in the affected participants, there was no consistency in the frequency pattern of hearing loss. The current study showed that SNHL is a frequent complication in children and adolescents with SCD. About 25% of children and adolescents with SCD experienced SNHL, which disproportionately affected males. Frequent audiometry should be carried out to check the children’s hearing levels and identify any early hearing losses so that interventions can be made to perhaps prevent associated speech and language issues that might cause educational challenges.

14 September 2024 in Hemato
Verified
Journal Article
Open access
PDF file
CPCitation: To be added by editorial staff during Production.
Citation: To be added by editorial staff during Production.
LRLucia Ruggieri
Lucia Ruggieri
HAHafsat Rufai Ahmad
Hafsat Rufai Ahmad
AHABDULAZIZ HASSAN
ABDULAZIZ HASSAN
IIIsmaila Nda Ibrahim
Ismaila Nda Ibrahim
BIBaba Inusa
Baba Inusa
Background: Sickle cell disease (SCD) is an autosomal recessive haemoglobin disorder, affecting about 7.74 million individuals worldwide, but it is more prevalent among Africans and Asians. SCD is characterised by many complications, and it is a major health issue in Nigeria, the country with the largest burden of the disease globally. This work aims to present the design and implementation of electronic registries (ER) for SCD in a tertiary hospital in Nigeria. Methods: Registry design was initiated during a staff exchange programme within the ARISE initiative (EU grant agreement no. 824021). Ethical approval was obtained, and paper records were retrieved and transferred into one adult and one paediatric database, developed with Microsoft Access. Results: Data from 2659 SCD patients were entered in the ERs, including 698 (26.3%) adults and 1961 (73.7%) children. There were 287 (41%) male adults, 404 (58%) female and 7 (1%) patients whose gender was missing. There were 1041 (53.1%) male children, 906 (46.2%) female and 14 (0.7%) whose gender was missing. Information on phenotype was available for 2385 subjects, and most of them (2082, 87.3%) were SS. The most prevalent SCD-related complication was painful events (26.6% in adults and 68.7% in children, considering valid cases). Conclusions: About 60% of SCD patients in the centre were included in the ERs providing useful, hands-on recommendations for future ER design in SCD. These ERs might be an appropriate tool for collecting and analysing SCD patients’ data.

1 May 2018 in The Journal of Community and Supportive Oncology
Verified
Journal Article
Closed access
PDF file
HAHafsat Rufai Ahmad
Hafsat Rufai Ahmad
Colon cancer is not common in childhood even though cases have been reported in children and adolescents.1,2 Although it is sporadic, it can arise in the settin

1 January 2014 in Nigerian Journal of Basic and Clinical Sciences
Verified
Journal Article
Closed access
PDF file
MGMahmud Jahun Gambo
Mahmud Jahun Gambo
ULUmar Muhammad Lawan
Umar Muhammad Lawan
WOWilliam Nuhu Ogala
William Nuhu Ogala
HAHafsat Rufai Ahmad
Hafsat Rufai Ahmad
Introduction: Tuberculosis (TB) is a serious public health problem associated with high morbidity and mortality. BCG vaccination as part of TB prevention strategy is faced with many challenges. The study sought to determine post BCG vaccination scarring and tuberculin reactivity, which may serve as useful indicators of routine BCG vaccination in infants. Materials and Methods: The study was descriptive cross-sectional. Infants were selected and physically examined for presence and size of BCG scar. Mantoux test was performed. Data were analyzed using statistical package for the social sciences software (SPSS version 16.0). Chi-square and Fisher's exact tests were used for association between categorical variables while Pearson's correlation co-efficient was used for the correlation between BCG scar size and Mantoux reaction. P ≤ 0.05 was considered significant. Results: The male:female ratio of the subjects was 1.6:1.0 with a mean birth weight of 3.2 ± 0.4kg.Mean age at Mantoux test was 19.0 ± 3.0 weeks and the prevalence of BCG scar was 81.5% with a mean scar size of 5.3 ± 3.2mm. Mantoux test was positive in 202 (56.7%), negative in 133 (37.4%), and indeterminate in 21 (5.9%) infants. The Mantoux reaction was significantly associated with the age interval between BCG administration and time of Mantoux test (χ2 = 54.17, P < 0.05), the infants' gender (χ2 = 31.23, P < 0.05) and their nutritional status (χ2 = 22.60, P < 0.05). The reaction was not significantly associated with the social class of the infants' parents. Conclusion: The study demonstrated high prevalence of BCG scar and high Tuberculin skin test reaction. Regular evaluation of BCG vaccination is recommended using TST and scar observation as adjuncts to strengthen BCG vaccination processes for effective tuberculosis prevention.

1 January 2017 in Case Reports in Oncological Medicine
Verified
Journal Article
Open access
PDF file
HAHafsat Rufai Ahmad
Hafsat Rufai Ahmad
JAJamilu Faruk Abdullahi
Jamilu Faruk Abdullahi
MBM A Bugaje
M A Bugaje
ASA Solomon
A Solomon
MSM O A Samaila
M O A Samaila
RAR M Akuse
R M Akuse
Malignancies have been reported to occur in people with sickle cell disease. Renal medullary carcinoma (RMC), also tagged seventh sickle cell nephropathy, is an aggressive cancer seen almost exclusively in people with sickle cell disease with more than 160 cases reported worldwide, but only few cases were reported in patients with sickle cell anaemia (HBSS) and from Nigeria. Sarcomatoid renal cell carcinoma is a renal tumour of any histologic variant containing foci of high‐grade malignant spindle cells. We report an adolescent girl with sickle cell anaemia (HBSS) who presented with left renal tumour, histology of which confirmed a diagnosis of sarcomatoid renal cell carcinoma (sRCC). Surgical debulking and palliative care with chemotherapy were given, and she demised 10 months after. The rarity of the case and challenges of managing a cancer in the background of a chronic haematologic disorder are highlighted.